4.4 Article

Identification of a novel pathogenic deep intronic variant in PTEN resulting in pseudoexon inclusion in a patient with juvenile polyps

Related references

Note: Only part of the references are listed.
Review Genetics & Heredity

Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome

Ulrika S. S. Petersen et al.

Summary: Accurate pre-mRNA splicing is crucial for normal gene expression. Activation of pseudoexons, nonfunctional intronic sequences, poses a risk of disease, but is challenging to predict and often goes undetected. Pseudoexon activation is mainly based on deep intronic sequence variants and is commonly missed by conventional diagnostic procedures, making it an underreported disease mechanism.

HUMAN MUTATION (2022)

Article Gastroenterology & Hepatology

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the US Multi-Society Task Force on Colorectal Cancer

C. Richard Boland et al.

Summary: Gastrointestinal hamartomatous polyposis syndromes are rare genetic disorders associated with an increased risk of intestinal and extraintestinal tumors. The diagnosis is based on clinical criteria and genetic testing. The treatment focuses on preventing bleeding and obstruction, as well as monitoring for cancer risk. Management recommendations for these syndromes are limited.

GASTROINTESTINAL ENDOSCOPY (2022)

Review Genetics & Heredity

Revised Danish guidelines for the cancer surveillance of patients with Cowden Syndrome

Maja Patricia Smerdel et al.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2020)

Review Genetics & Heredity

Hamartomatous polyposis syndromes: A review

Anne Marie Jelsig et al.

ORPHANET JOURNAL OF RARE DISEASES (2014)